Cambridge Heart Inc. hires investor relations firm Wolfe Axelrod Weinberger Associates to tap the micro-cap investment sector.
Cambridge Heart Inc. (OTC:CAMH) is looking to tap the micro-cap investment sector, hiring an outside firm to tout its cardiac disease testing technology.
The Tewksbury, Mass.-based firm said it tapped Wolfe Axelrod Weinberger Associates as its investor relations agency, effective immediately.
“Over the past year, Cambridge Heart has attained many of its strategic goals and is poised for significant growth in 2011 and beyond,” president and CEO Ali Haghighi-Mood said in prepared remarks, noting its new IR firm’s reach into the micro-cap sector and its experience with “emerging” medical device makers.
Cambridge Heart pulled in $752,000 in an options deal last month. Late last year, the company raised close to $3 million in a private placement.
CAMH reported third-quarter losses of $1.1 million, or 2 cents per diluted share, on revenue of $792,734 during the three months ended Sept. 30, 2010. That compares with a loss of $1.7 million, or 3 cents per diluted share, on sales of $798,345 during the same period in 2009.
The company’s shares were down more than 11 percent to 24 cents in mid-morning trading.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
These Are the Top-Rated Autism Therapy Centers in Texas
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.